What's breaking now, across thousands of outlets.
Researchers at the Icahn School of Medicine at Mount Sinai have identified biological mechanisms that may contribute to CAR-T cell-associated enterocolitis, a serious inflammatory condition of the intestine that can occur after a type of CAR-T cell therapy for multiple myeloma.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
The corporatization of the health care system by private equity has come with significant costs. While private equity’s ownership of hospitals may earn millions for their investors, they have put…
The Food and Drug Administration recently approved a new flu vaccine that tested well in older adults. But the federal agency responsible for telling doctors and the general public how to use it has…
Drug development has a lab-to-clinic translation ...
Most people occasionally misplace their car keys or forget a dentist's appointment, especially as they get older. When memory lapses occur regularly and interfere with daily life, however, they could…
A small drug developer with ...
